Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
Clinical trial NCT01593722 · COMPLETED
Trial details
- NCT number
- NCT01593722
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-08-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.